Anlon Healthcare Ltd

Thu 27/08/2026,15:59:3 | NSE : AHCL

₹15.600.49 (3.24%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 15.10

Previous Close

₹ 15.11

Volume

4430962

Mkt Cap ( ₹ Cr)

₹ 82.92

High

₹ 15.80

Low

₹ 15.10

52 Week High

₹ 17.28

52 Week Low

₹ 9.08

Book Value Per Share

₹ 36.87

Dividend Yield

0.00

Face Value

₹ 2.00

What's Your Call?

Collective community sentiment on Anlon Healthcare Ltd

Your Vote -

Buy

77.78%

Hold

11.11%

Sell

11.11%

77.78%

9 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anlon Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anlon Healthcare - Anlon Healthcare Limited Has Informed The Exchange Regarding Corrigendum To Notice Of Annual General Meeti

    25 Aug 2026, 11:31PM We have attached herewith corrigendum.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Corrigendum

    25 Aug 2026, 11:26PM Anlon Healthcare Limited has informed the Exchange regarding Corrigendum to Notice of Annual General Meeting to be held on September 05, 2026

  • Anlon Healthcare - Copy of Newspaper Publication

    17 Aug 2026, 11:53AM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  • Anlon Healthcare - Reg. 34 (1) Annual Report.

    14 Aug 2026, 11:56PM We have attached herewith Annual Report for the financial year 2025-2026.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Notice Of 13Th Annual General Meeting Of Anlon Healthcare Limited

    14 Aug 2026, 11:48PM We have attached herewith Notice of Annual General Meeting.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Shareholders meeting

    14 Aug 2026, 11:39PM Anlon Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 05, 2026

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    14 Aug 2026, 6:10PM We have attached herewith Monitoring Agency Report for the quarter ended June 30, 2026.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Monitoring Agency Report

    14 Aug 2026, 6:07PM Submission of Monitoring Agency Report for the quarter ended June 30, 2026.

  • Anlon Healthcare - Corporate Action - Fixes Book Closure For Annual General Meeting

    13 Aug 2026, 8:54PM We have attached herewith intimation for fixes Book Closure for Annual General Meeting.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Corporate Action Record Date Fixed For Annual General Meeting

    13 Aug 2026, 8:48PM We have attached herewith intimation for record fixed for Annual General Meeting.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Record Date

    13 Aug 2026, 8:45PM Anlon Healthcare Limited has informed the Exchange that Record date for the purpose of Annual General Meeting is 28-Aug-2026.

  • Anlon Healthcare - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, August 13, 2026

    13 Aug 2026, 8:36PM We have attached herewith outcome of Board Meeting.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Outcome of Board Meeting

    13 Aug 2026, 8:33PM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2026.

  • Anlon Healthcare - Others

    13 Aug 2026, 1:16PM Anlon Healthcare Limited has informed the Exchange about Others

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    13 Aug 2026, 1:21PM We have attached herewith revised intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\n

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Aug 2026, 2:52PM Anlon Healthcare Limited has informed the Exchange about Transcript

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    12 Aug 2026, 2:56PM We have attached herewith earning call transcript.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Board Meeting Intimation for Rescheduled/Postponement Of Meeting

    11 Aug 2026, 8:02PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and

  • Anlon Healthcare - Agreements

    8 Aug 2026, 6:12PM Anlon Healthcare Limited has informed the Exchange about the Share Swap Agreement ( SSA )

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    8 Aug 2026, 6:01PM Anlon Healthcare Limited has informed the exchange about the Share Swap Agreement (\SSA\).

  • Anlon Healthcare - Trading Window

    6 Aug 2026, 9:05PM Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Anlon Healthcare - Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The Company

    6 Aug 2026, 9:00PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    6 Aug 2026, 7:58PM We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Aug 2026, 7:45PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Investor Presentation

    5 Aug 2026, 12:16PM Anlon Healthcare Limited has informed the Exchange about Investor Presentation

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    5 Aug 2026, 12:21PM We have attached herewith Investor Presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record. \r\n

  • Anlon Healthcare - Copy of Newspaper Publication

    1 Aug 2026, 5:13PM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    31 Jul 2026, 12:57PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Jul 2026, 12:52PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    31 Jul 2026, 10:48AM We have attached press release for Financial Results for the Quarter Ended June 30, 2026.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you

  • Anlon Healthcare - Press Release

    31 Jul 2026, 10:44AM Anlon Healthcare Limited has informed the Exchange regarding a press release dated July 31, 2026, titled ""Press release of Financial Results for the

  • Anlon Healthcare - Financial Results For The Quarter Ended June 30, 2026

    30 Jul 2026, 11:57AM We have attached herewith financial results for the quarter ended June 30, 2026.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Integrated Filing- Financial

    30 Jul 2026, 11:48AM Financial Results for the quarter ended June 30, 2026

  • Anlon Healthcare - Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2026

    30 Jul 2026, 11:47AM We have attached herewith outcome of Board Meeting to consider and approve the Financial Results for the quarter ended June 30, 2026.\r\n\r\nKindly ta

  • Anlon Healthcare - Outcome of Board Meeting

    30 Jul 2026, 11:44AM Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Anlon Healthcare - Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30, 2026

    27 Jul 2026, 8:46PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and

  • Anlon Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 8:30PM As of June 2026, 52.68% is owned by Indian Promoters and 47.32% by Public. <p align=justify> Institutional holds 2.90% (Insurance Companies 0.06%) and

  • Anlon Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    20 Jul 2026, 7:20PM We have attached herewith RTA Certificate as per Reg. 74(5) of SEBI (DP) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Structural Digital Database

    20 Jul 2026, 7:05PM SDD COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED ON JUNE 30, 2026

  • Anlon Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    20 Jul 2026, 6:30PM Anlon Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anlon Healthcare - General Updates

    11 Jul 2026, 4:20PM Anlon Healthcare Limited has informed the Exchange about General Updates

  • Anlon Healthcare - Announcement For Incorporation Of Subsidiary Company

    11 Jul 2026, 4:17PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Announcement Of Incorporated Of Subsidiary Company Of Anlon Healthcare Limited

    9 Jul 2026, 8:32PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - General Updates

    9 Jul 2026, 8:28PM Anlon Healthcare Limited has informed the Exchange about General Updates

  • Anlon Healthcare - Disclosure Regarding Interview/Podcast Of Chairman & Managing Director With Sumit Mehrotra, Former Senior

    6 Jul 2026, 8:41PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - General Updates

    6 Jul 2026, 8:37PM Disclosure regarding interview/podcast of Chairman & Managing Director with Sumit Mehrotra, former Senior Anchor @cnbcawaaz

  • Anlon Healthcare - Updates

    1 Jul 2026, 12:30PM Anlon Healthcare Limited has informed the Exchange regarding interview of Chairman & Managing Director with Money TV'.

  • Anlon Healthcare - Outcome of Board Meeting

    1 Jul 2026, 11:34AM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 01, 2026.

  • Anlon Healthcare - Disclosure Regarding Interview Of Chairman & Managing Director With Money TV

    1 Jul 2026, 12:40PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Board Meeting Outcome for Incorporation Of Subsidiaries Of Anlon Healthcare Limited

    1 Jul 2026, 11:37AM We have enclosed herewith Outcome of Board Meeting held on Wednesday, July 01, 2026.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Trading Window

    30 Jun 2026, 11:16AM Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Anlon Healthcare - Reply to Clarification- Financial results

    25 Jun 2026, 2:21PM The Exchange had sought clarification from Anlon Healthcare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listi

  • Anlon Healthcare - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Invitation For TV Interview On NDTV Prof

    11 Jun 2026, 11:12AM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Updates

    11 Jun 2026, 11:03AM Anlon Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Invitation for TV Inte

  • Anlon Healthcare - Intimation Regarding Media Interaction Of Chairman & Managing Director

    9 Jun 2026, 6:33PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Updates

    9 Jun 2026, 6:28PM Anlon Healthcare Limited has informed the Exchange regarding Media Interaction of Chairman & Managing Director.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Jun 2026, 11:18AM Anlon Healthcare Limited has informed the Exchange about Transcript

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    9 Jun 2026, 11:23AM We have attached herewith earning call transcript as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    3 Jun 2026, 7:21PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Jun 2026, 7:13PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Investor Presentation

    3 Jun 2026, 12:40PM Anlon Healthcare Limited has informed the Exchange about Investor Presentation

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    3 Jun 2026, 12:44PM We have attached herewith investor presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\

  • Anlon Healthcare - Press Release

    30 May 2026, 11:32AM Anlon Healthcare Limited has informed the Exchange regarding a press release dated May 29 2026, titled ""Intimation for Press release of Audited Finan

  • Anlon Healthcare - Copy of Newspaper Publication

    30 May 2026, 11:23AM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication dated 30th May, 2026 regarding publication of extract of Audite

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 May 2026, 11:37AM Intimation for Press Release of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year ended March 31, 2026.

  • Anlon Healthcare - Considered, Approved And Taken On Record Audited Financial Results For The Quarter And Year Ended 31St Mar

    29 May 2026, 12:52PM We have attached herewith the Audited Financial Results (Standalone and Consolidated) together with the Report of the Auditor thereon.\r\n\r\nPlease t

  • Anlon Healthcare Q4 net profit down 41.20% at Rs 9.79 cr

    29 May 2026, 12:50PM The company reported standalone net profit of Rs 9.79 crore for the quarter ended March 31, 2026 as compared to Rs 16.65 crore in the same period last

  • Anlon Healthcare - Board Meeting Outcome for To Consider And Approve Financial Results For The Quarter And Year Ended March 3

    29 May 2026, 12:23PM We have attached herewith outcome of Board Meeting held on Friday, May 29, 2026.\r\n\r\nKindly take the same on your record. \r\n\r\nThank you.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 May 2026, 7:09PM We have attached herewith Intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    28 May 2026, 7:06PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anlon Healthcare Ltd stock 

Name March-26 March-25 March-24 March-23
Assets 255.372 138.7691 95.5946 73.761
Liabilities 255.372 138.7691 95.5946 73.761
Equity 53.1515 39.8515 16 12
Gross Profit 46.1378 32.2087 15.4611 12.4148
Net Profit 27.8082 20.5179 9.6571 5.82
Cash From Operating Activities -46.3581 -22.5517 -3.226 -2.8497
NPM(%) 15.75 17.05 14.5 5.15
Revenue 176.4987 120.2866 66.5837 112.8774
Expenses 130.3609 88.0779 51.1226 100.4626
ROE(%) 14.18 10.46 4.92 2.96

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Anlon Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 890.25 2.36 22.52 8.63 -26.19 0.56
Lotus Eye Hospital and Institute Ltd 112.63 0.91 1609.00 31.46 0.39 0.00
Vaishali Pharma Ltd 8.33 1.96 26.03 197.39 15.42 0.00
Astec Lifesciences Ltd 585.90 -1.28 0.00 33.71 -363.14 0.00

Company Info

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.2025-The Company has entered into a Share Purchase Agreement between the Anlon Healthcare Limited and Apiqo Organics Private Limited.

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.2025-The Company has entered into a Share Purchase Agreement between the Anlon Healthcare Limited and Apiqo Organics Private Limited.

Parent Organisation

Anlon Healthcare Ltd.

Founded

19/11/2013

Managing Director

Mr.Punitkumar R Rasadia

NSE Symbol

AHCLEQ

FAQ